STAMFORD, Conn., Jan. 26 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. , announced today that it will present at the Brean Murray, Carret & Co. Small Cap Institutional Investor Conference on February 1, 2006. The presentation is scheduled for 3:00 p.m. ET at the Grand Hyatt New York.
M.S. Koly, Delcath’s President and Chief Executive Officer, will provide an overview of the company’s clinical programs for the treatment of advanced stage liver cancer. A live audio webcast of the presentation can be accessed on the company’s website at www.delcath.com. A replay of the presentation will be available for 90 days.
About Delcath Systems, Inc.
Delcath Systems is a developer of isolated perfusion technology for organ or region-specific delivery of therapeutic agents. The company’s intellectual property portfolio currently consists of 12 patents on a worldwide basis, including the United States, Europe, Asia and Canada.
In May 2005, Delcath received fast-track status from the U.S. FDA for the treatment of metastatic melanoma in the liver with melphalan using the Delcath system. For more information, please visit the Company’s website, www.delcath.com.
This release contains “forward-looking statements” based on current expectations but involving known and unknown risks and uncertainties. Actual results or achievements may be materially different from those expressed or implied. Delcath plans and objectives are based on assumptions involving judgments with respect to future economic, competitive and market conditions, its ability to consummate, and the timing of, acquisitions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond its control. Therefore, there can be no assurance than any forward-looking statement will prove to be accurate.
Delcath Systems, Inc.
CONTACT: M. S. Koly, Chief Executive Officer of Delcath Systems, Inc.+1-203-323-8668; or Todd Fromer, +1-212-896-1215, or tfromer@kcsa.com, orMichael Cimini, +1-212-896-1233, or mcimini@kcsa.com, both of KCSAWorldwide
Web site: http://www.delcath.com/
